
Opinion|Videos|October 31, 2024
Overcoming Treatment Barriers: Strategies for Success
Author(s)Toby Maher, MD, PhD
Key Takeaways
- Financial constraints and limited access to healthcare facilities are significant barriers to appropriate treatment for patients.
- Implementing financial assistance programs and expanding telemedicine services can help overcome these barriers.
Toby Maher, MD, PhD, discusses the various barriers that frequently hinder patients with idiopathic pulmonary fibrosis (IPF) from receiving appropriate treatment and shares effective strategies he has implemented to overcome these challenges.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What barriers often prevent patients from receiving appropriate treatment, and what strategies have you implemented to address these challenges?
Advertisement
Related to this article

Shorter telomere length was linked to a usual interstitial pneumonia pattern (UIP) on CT in patients with ILD, per research presented at CHEST 2026.

Non-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.

The once weekly self-injected treatment is the first dual-binding nanobody C5 inhibitor approved for adults with AChR antibody-positive gMG.

Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.

Non-CF bronchiectasis prevalence rose across commercial, Medicare, and Medicaid plans from 2016 to 2024, while incidence stayed relatively stable.

Low awareness that fatty liver can silently progress and that MASH fibrosis is treatable drives missed follow-up testing, says Rohit Loomba, MD.
Advertisement
Advertisement
Trending on AJMC
1
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
2
FDA Approves Weekly Gefurulimab for Generalized Myasthenia Gravis
3
No Surprises Act Arbitration Added $8.39B in 2025 Plan Obligations
4
Nondrug Therapies Ease Cough in Lung Cancer, Pulmonary Rehab Leads Pack
5



